CORREVIO (UK) LTD.

Company number 06481819

Date	Type	Description	View / Download
14 Sep 2020	MA	Memorandum and Articles of Association	(31 pages)
14 Sep 2020	MA	Memorandum and Articles of Association	(31 pages)
14 Sep 2020	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association	(2 pages)
16 Jul 2020	AA	Accounts for a small company made up to 31 December 2019	(14 pages)
17 Jun 2020	TM01	Termination of appointment of Justin Andrew Renz as a director on 27 May 2020	(1 page)
17 Jun 2020	TM01	Termination of appointment of Sheila Mary Grant as a director on 27 May 2020	(1 page)
17 Jun 2020	AP01	Appointment of Mr. Vikram Laxman Kamath as a director on 27 May 2020	(2 pages)
17 Jun 2020	AP01	Appointment of Mr. Adeel Ahmad as a director on 27 May 2020	(2 pages)
28 May 2020	MR04	Satisfaction of charge 064818190001 in full	(1 page)
27 Jan 2020	CS01	Confirmation statement made on 23 January 2020 with no updates	(3 pages)
11 Sep 2019	AA	Accounts for a small company made up to 31 December 2018	(14 pages)
24 Jul 2019	AD02	Register inspection address has been changed from C/O Mccarthy Tetrault 125 Old Broad Street London EC2N 1AR England to C/O Mccarthy Tetrault 1 Angel Court 18th Floor London EC2R 7HJ	(1 page)
23 Jul 2019	AD03	Register(s) moved to registered inspection location C/O Mccarthy Tetrault 125 Old Broad Street London EC2N 1AR	(1 page)
27 Mar 2019	RP04CS01	Second filing of Confirmation Statement dated 23/01/2019	(6 pages)
27 Mar 2019	CH01	Director's details changed for Ms Sheila Mary Grant on 25 March 2019	(2 pages)
06 Mar 2019	PSC02	Notification of Correvio Pharma Corp. as a person with significant control on 15 May 2018	(2 pages)
06 Mar 2019	PSC07	Cessation of Cardiome Pharma Corp. as a person with significant control on 15 May 2018	(1 page)
06 Mar 2019	PSC05	Change of details for Correvio Pharma Corp. as a person with significant control on 15 May 2018	(2 pages)
31 Jan 2019	CS01	Confirmation statement made on 23 January 2019 with no updates ANNOTATION Clarification a second filed CS01 (statement of capital change and shareholder information change) was registered on 27/03/2019.	(4 pages)
28 Jan 2019	PSC05	Change of details for Cardiome Pharma Corp. as a person with significant control on 15 May 2018	(2 pages)
05 Jul 2018	AA	Accounts for a small company made up to 31 December 2017	(14 pages)
24 Jan 2018	CS01	Confirmation statement made on 23 January 2018 with no updates	(3 pages)
26 Oct 2017	AP01	Appointment of Ms Sheila Mary Grant as a director on 17 October 2017	(2 pages)
26 Oct 2017	TM01	Termination of appointment of David Douglas Mcmasters as a director on 17 October 2017	(1 page)
25 Sep 2017	AA	Accounts for a small company made up to 31 December 2016	(13 pages)